Platelet rich plasma or PRP is an injection containing a concentration of platelet-rich plasma which is injected into injured muscles or tendons. PRP has growth factors and proteins that help the body's innate healing processes. PRP therapy can potentially help accelerate tissue healing by delivering an increased level of growth factors and proteins to an injured area.
The global Europe Platelet rich Plasma Market is estimated to be valued at US$ 110.4 Mn in 2023 and is expected to exhibit a CAGR of 10 % over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends driving the growth of the Europe platelet rich plasma market is rising incidences of musculoskeletal disorders. Musculoskeletal conditions are on the rise owing to sedentary lifestyles and growing elderly population. Knee osteoarthritis is one of the most common joint problem among adults. PRP is gaining prominence as an effective treatment option for orthopedic disorders as it expedites the tissue healing process by delivering growth factor proteins to injured areas. PRP therapy offers advantages such as minimal invasion, reduced healing time and lower risk of infection compared to surgical interventions. Growing utilization of PRP injections in sports medicine and cosmetic surgeries is also contributing to the market expansion.
Segment Analysis
The Europe platelet rich plasma market is dominated by PRP kits and systems segment owing to advantages such as easy availability and storage of plasma. PRP kits and systems are used for easy collection, separation and activation of platelet rich plasma from whole blood. PRP kits and systems contain collection tubes, centrifuges and other accessories required for PRP therapies.
Key Takeaways
The Europe Platelet Rich Plasma Market Size is expected to witness high growth. The global Europe Platelet rich Plasma Market is estimated to be valued at US$ 110.4 Mn in 2023 and is expected to exhibit a CAGR of 10 % over the forecast period 2023 to 2030.
Regional analysis related content comprises: The Germany platelet rich plasma market dominates the Europe region owing to increase in awareness about PRP therapies and supportive regulatory framework in the country. In addition, presence of advanced healthcare infrastructure and major market players boost the adoptions of PRP therapies in Germany.
Key players related content comprises: Key players operating in the Europe platelet rich plasma market are GE Healthcare, Koninklijke Philips N.V., Welch Allyn, Spacelabs Healthcare, A&D Company, Limited, SunTech Medical, Inc., OMRON Healthcare, Inc.
Get More Insights Here
https://www.newsstatix.com/europe-platelet-rich-plasma-market-size-share-growth-outlook-2023/
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Italiano
Russian
Romaian